These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9777167)

  • 1. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy.
    Kegeles LS; Humaran TJ; Mann JJ
    Biol Psychiatry; 1998 Sep; 44(6):382-98. PubMed ID: 9777167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
    Reddy R; Keshavan MS
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance spectroscopy in schizophrenia].
    Delamillieure P; Constans JM; Fernandez J; Dollfus S
    Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Reid MA; White DM; Kraguljac NV; Lahti AC
    Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
    Moore GJ; Galloway MP
    Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.
    Wijtenburg SA; Yang S; Fischer BA; Rowland LM
    Neurosci Biobehav Rev; 2015 Apr; 51():276-95. PubMed ID: 25614132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].
    Wobrock T; Scherk H; Falkai P
    Radiologe; 2005 Feb; 45(2):124-30, 132-6. PubMed ID: 15645203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T.
    Yoo CH; Song KH; Lim SI; Lee DW; Woo DC; Choe BY
    Neurosci Lett; 2017 Jan; 637():57-63. PubMed ID: 27894920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia.
    Dwyer GE; Hugdahl K; Specht K; Grüner R
    Curr Top Med Chem; 2018; 18(21):1908-1924. PubMed ID: 30499397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature.
    Hellem T; Shi X; Latendresse G; Renshaw PF
    J Am Psychiatr Nurses Assoc; 2015; 21(4):244-75. PubMed ID: 26282670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy of neurotransmitters in human brain.
    Novotny EJ; Fulbright RK; Pearl PL; Gibson KM; Rothman DL
    Ann Neurol; 2003; 54 Suppl 6():S25-31. PubMed ID: 12891651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
    Cecil KM; Lenkinski RE; Gur RE; Gur RC
    Neuropsychopharmacology; 1999 Feb; 20(2):131-40. PubMed ID: 9885793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
    Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
    Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy changes after antipsychotic treatment.
    Szulc A; Galinska-Skok B; Waszkiewicz N; Bibulowicz D; Konarzewska B; Tarasow E
    Curr Med Chem; 2013; 20(3):414-27. PubMed ID: 23157634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging and spectroscopy of regional brain structure in a 10-year-old boy with elevated blood lead levels.
    Trope I; Lopez-Villegas D; Lenkinski RE
    Pediatrics; 1998 Jun; 101(6):E7. PubMed ID: 9606249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR spectroscopic studies of the brain in psychiatric disorders.
    Maddock RJ; Buonocore MH
    Curr Top Behav Neurosci; 2012; 11():199-251. PubMed ID: 22294088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.
    Stanley JA; Pettegrew JW; Keshavan MS
    Biol Psychiatry; 2000 Sep; 48(5):357-68. PubMed ID: 10978719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of proton magnetic resonance spectroscopy findings in sport-related concussion.
    Gardner A; Iverson GL; Stanwell P
    J Neurotrauma; 2014 Jan; 31(1):1-18. PubMed ID: 24047225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.